Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
Published 4 months, 1 week ago
Description
In today’s Pharmaceutical Executive Daily, Johnson & Johnson reaches an agreement with the Trump administration while continuing its $55 billion U.S. investment plan, Bristol Myers Squibb outlines its long-term strategic focus at JPMorgan 2026, and Pfizer details its pivot from COVID-era products toward pipeline execution.